Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.

Benson, A B; Olopade, O I; Ratain, M J; Rademaker, A; Mobarhan, S; Stucky-Marshall, L; French, S; Dolan, M E

Benson, A B; Olopade, O I; Ratain, M J; Rademaker, A; Mobarhan, S; Stucky-Marshall, L; French, S; Dolan, M E.

Affiliation

Benson AB; Department of Medicine, Northwestern University Medical School, and Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois 60611, USA. a-benson@northwestern.edu

Clin Cancer Res ; 6(10): 3870-7, 2000 Oct.

Article in En | MEDLINE | ID: mdl-11051232

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Breast Neoplasms / Colonic Polyps / Anticarcinogenic Agents Limits: Female / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links